Erectile Aid Use in Post-phalloplasty and Post-metoidioplasty Transgender Patients: an Epidemiological Survey

Status: Recruiting
Location: See location...
Intervention Type: Diagnostic test
Study Type: Observational
SUMMARY

This study seeks to explore the various methods used by transgender men for sexual intercourse following phalloplasty or metoidioplasty, focusing on their satisfaction with different erectile aids, as well as the satisfaction of their partners. Phalloplasty and metoidioplasty are gender-affirming surgeries that often require additional aids to achieve the desired sexual function, particularly for penetration. While internal erectile prostheses are common after phalloplasty, they come with high complication rates, leading some patients to opt for non-surgical aids. However, the effectiveness and comfort of these aids are not well-documented. This study aims to fill this gap by examining the types of aids transgender men use, how well these aids meet their sexual needs, and how satisfied both they and their partners are with the outcomes, providing much-needed insight for healthcare providers and patients alike.

Eligibility
Participation Requirements
Sex: Female
Minimum Age: 18
Healthy Volunteers: t
View:

• Patient and partner age ≥ 18 years.

• Transgender or gender non-conforming individuals (and their partners).

• Patients have undergone phalloplasty or metoidioplasty as a form of genital gender affirming surgery.

• ≥6 months after phalloplasty or metoidioplasty (any type of flap or technique is allowed).

• Sexually active or has been sexually active since phalloplasty or metoidioplasty with a partner or main sexual partner.

• Voluntarily agreed that the data may be used for an anonymized scientific study.

Locations
Other Locations
Belgium
Department of Urology, University Hospital Ghent
RECRUITING
Ghent
Contact Information
Primary
Wietse Claeys, MD
wietse.claeys@ugent.be
003293322276
Backup
Anne-Françoise Spinoit, MD, PhD
anne-francoise.spinoit@uzgent.be
003293322276
Time Frame
Start Date: 2024-07-06
Estimated Completion Date: 2025-06-30
Participants
Target number of participants: 1000
Related Therapeutic Areas
Sponsors
Leads: University Hospital, Ghent

This content was sourced from clinicaltrials.gov